2024 Q3 Form 10-Q Financial Statement

#000141057824001118 Filed on July 29, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $8.925M $8.470M
YoY Change 13.87% 8.09%
Cost Of Revenue $1.823M $1.764M
YoY Change 1.96% -1.29%
Gross Profit $7.102M $6.706M
YoY Change 17.39% 10.86%
Gross Profit Margin 79.57% 79.17%
Selling, General & Admin $6.942M $5.982M
YoY Change 26.56% -1.03%
% of Gross Profit 97.75% 89.2%
Research & Development $1.151M $1.221M
YoY Change -41.13% -39.94%
% of Gross Profit 16.21% 18.21%
Depreciation & Amortization $596.0K $596.0K
YoY Change 4.56% 3.29%
% of Gross Profit 8.39% 8.89%
Operating Expenses $8.093M $7.203M
YoY Change 8.78% -10.82%
Operating Profit -$991.0K -$497.0K
YoY Change -28.71% -75.49%
Interest Expense -$211.0K -$238.0K
YoY Change -702.86% -532.73%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.202M -$735.0K
YoY Change -11.62% -62.75%
Income Tax
% Of Pretax Income
Net Earnings -$1.202M -$735.0K
YoY Change -11.29% -62.75%
Net Earnings / Revenue -13.47% -8.68%
Basic Earnings Per Share -$0.10 -$0.06
Diluted Earnings Per Share -$0.10 -$0.06
COMMON SHARES
Basic Shares Outstanding 11.88M 11.64M
Diluted Shares Outstanding 11.96K 11.70M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.478M $5.086M
YoY Change 67.52% 17.81%
Cash & Equivalents $5.478M $5.086M
Short-Term Investments
Other Short-Term Assets $1.042M $1.050M
YoY Change 57.88% 97.74%
Inventory
Prepaid Expenses
Receivables $4.876M $5.420M
Other Receivables $0.00 $0.00
Total Short-Term Assets $11.40M $11.56M
YoY Change 36.59% 21.28%
LONG-TERM ASSETS
Property, Plant & Equipment $228.0K $222.0K
YoY Change -5.39% 2.78%
Goodwill $6.615M $4.001M
YoY Change 65.33% 0.0%
Intangibles $10.59M $5.628M
YoY Change 80.34% -5.92%
Long-Term Investments
YoY Change
Other Assets $128.0K $123.0K
YoY Change 23.08% 20.59%
Total Long-Term Assets $17.99M $10.45M
YoY Change 64.92% -5.63%
TOTAL ASSETS
Total Short-Term Assets $11.40M $11.56M
Total Long-Term Assets $17.99M $10.45M
Total Assets $29.39M $22.00M
YoY Change 52.64% 6.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.481M $2.688M
YoY Change 64.98% 8.39%
Accrued Expenses $194.0K $211.0K
YoY Change -47.57% -49.16%
Deferred Revenue $7.587M $7.050M
YoY Change 19.33% 6.66%
Short-Term Debt $2.348M $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $13.61M $9.949M
YoY Change 23.55% -14.96%
LONG-TERM LIABILITIES
Long-Term Debt $6.796M $6.773M
YoY Change
Other Long-Term Liabilities $105.0K $105.0K
YoY Change -78.13% -81.12%
Total Long-Term Liabilities $6.901M $6.878M
YoY Change 1337.71% 1137.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.61M $9.949M
Total Long-Term Liabilities $6.901M $6.878M
Total Liabilities $22.04M $17.15M
YoY Change 91.78% 39.92%
SHAREHOLDERS EQUITY
Retained Earnings -$94.26M -$93.06M
YoY Change 7.33% 7.62%
Common Stock $1.000K $1.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.352M $4.857M
YoY Change
Total Liabilities & Shareholders Equity $29.39M $22.00M
YoY Change 52.64% 6.82%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$1.202M -$735.0K
YoY Change -11.29% -62.75%
Depreciation, Depletion And Amortization $596.0K $596.0K
YoY Change 4.56% 3.29%
Cash From Operating Activities $1.553M $410.0K
YoY Change -570.61% -184.02%
INVESTING ACTIVITIES
Capital Expenditures $445.0K $488.0K
YoY Change -24.58% -15.28%
Acquisitions
YoY Change
Other Investing Activities -$3.123M
YoY Change
Cash From Investing Activities -$3.568M -$488.0K
YoY Change 504.75% -15.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.407M -1.876M
YoY Change -2105.83% 1058.02%
NET CHANGE
Cash From Operating Activities 1.553M 410.0K
Cash From Investing Activities -3.568M -488.0K
Cash From Financing Activities 2.407M -1.876M
Net Change In Cash 392.0K -1.954M
YoY Change -137.69% 59.38%
FREE CASH FLOW
Cash From Operating Activities $1.553M $410.0K
Capital Expenditures $445.0K $488.0K
Free Cash Flow $1.108M -$78.00K
YoY Change -220.43% -92.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001362190
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
AUDIOEYE INC
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11711000
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11808000
CY2023Q4 us-gaap Debt Instrument Variable Interest Rate Type Extensible Enumeration
DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#PrimeRateMember
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38640
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-2939845
dei Entity Address Address Line1
EntityAddressAddressLine1
5210 East Williams Circle
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 750
dei Entity Address City Or Town
EntityAddressCityOrTown
Tucson
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85711
dei City Area Code
CityAreaCode
866
dei Local Phone Number
LocalPhoneNumber
331-5324
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
AEYE
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11879116
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5086000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9236000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
436000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
496000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5420000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4828000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1050000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
712000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
11556000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
14776000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
301000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
251000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
222000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
218000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
474000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
611000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8489000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7423000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5628000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5783000
CY2024Q2 us-gaap Goodwill
Goodwill
4001000
CY2023Q4 us-gaap Goodwill
Goodwill
4001000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
123000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
106000
CY2024Q2 us-gaap Assets
Assets
22004000
CY2023Q4 us-gaap Assets
Assets
25495000
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2688000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2339000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
211000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
312000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
7000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7050000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6472000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
2399000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9949000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11529000
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6773000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6727000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
319000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
417000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
10000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
105000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
105000
CY2024Q2 us-gaap Liabilities
Liabilities
17147000
CY2023Q4 us-gaap Liabilities
Liabilities
18788000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11808000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11711000
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
1000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
97912000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
96182000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-93056000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-89476000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
4857000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6707000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22004000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25495000
CY2024Q2 us-gaap Revenues
Revenues
8470000
CY2023Q2 us-gaap Revenues
Revenues
7836000
us-gaap Revenues
Revenues
16553000
us-gaap Revenues
Revenues
15608000
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
1764000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
1787000
us-gaap Cost Of Revenue
CostOfRevenue
3525000
us-gaap Cost Of Revenue
CostOfRevenue
3489000
CY2024Q2 us-gaap Gross Profit
GrossProfit
6706000
CY2023Q2 us-gaap Gross Profit
GrossProfit
6049000
us-gaap Gross Profit
GrossProfit
13028000
us-gaap Gross Profit
GrossProfit
12119000
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2971000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3253000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5974000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6496000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1221000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2033000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2543000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3779000
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3011000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2791000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5639000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5926000
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
7203000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
8077000
us-gaap Operating Expenses
OperatingExpenses
14156000
us-gaap Operating Expenses
OperatingExpenses
16201000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-497000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2028000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1128000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4082000
CY2024Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-238000
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
55000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-436000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
98000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-735000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1973000
us-gaap Net Income Loss
NetIncomeLoss
-1564000
us-gaap Net Income Loss
NetIncomeLoss
-3984000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11703000
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11703000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11738000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11738000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11706000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11706000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11688000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11688000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6707000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-160000
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
1686000
CY2024Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
883000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-829000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4915000
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
563000
CY2024Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
53000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-584000
CY2024Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
330000
CY2024Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
975000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-735000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
4857000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
10589000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-258000
CY2023Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
1118000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2011000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
9438000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
36000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-188000
CY2023Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
1031000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1973000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
8344000
us-gaap Profit Loss
ProfitLoss
-1564000
us-gaap Profit Loss
ProfitLoss
-3984000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1168000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1103000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
4000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
147000
us-gaap Share Based Compensation
ShareBasedCompensation
1858000
us-gaap Share Based Compensation
ShareBasedCompensation
2149000
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
16000
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
36000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
47000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
137000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
199000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-12000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
214000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
111000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
703000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-739000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
372000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-119000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-447000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-82000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-199000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-271000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
569000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-559000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
613000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-191000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
75000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
57000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
947000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
999000
aeye Payment To Patent Costs
PaymentToPatentCosts
13000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1035000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1056000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
663000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
53000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
36000
aeye Payments Related To Settlement Of Employee Shared Based Awards
PaymentsRelatedToSettlementOfEmployeeSharedBasedAwards
744000
aeye Payments Related To Settlement Of Employee Shared Based Awards
PaymentsRelatedToSettlementOfEmployeeSharedBasedAwards
446000
aeye Payments For Settlement Of Contingent Consideration
PaymentsForSettlementOfContingentConsideration
1677000
aeye Payments For Settlement Of Contingent Consideration
PaymentsForSettlementOfContingentConsideration
908000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2016000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
7000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
22000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3728000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1340000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4150000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2587000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9236000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6904000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5086000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4317000
aeye Non Cash Activity Of Common Stock Offering Costs Included In Accounts Payable
NonCashActivityOfCommonStockOfferingCostsIncludedInAccountsPayable
100000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the consolidated financial statements and during the reporting period. On an ongoing basis, management evaluates its estimates and judgments, including those related to stock-based compensation, allowance for doubtful accounts, and intangible assets. Actual results may differ from these estimates.</p>
aeye Subscription Revenue Indirect
SubscriptionRevenueIndirect
9704000
aeye Subscription Revenue Indirect
SubscriptionRevenueIndirect
8760000
aeye Subscription Revenue Direct
SubscriptionRevenueDirect
6849000
aeye Subscription Revenue Direct
SubscriptionRevenueDirect
6848000
us-gaap Revenues
Revenues
16553000
us-gaap Revenues
Revenues
15608000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7050000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6472000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
10000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7051000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6482000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4922000
CY2023 aeye Contract With Customer Liability Revenue Recognized Percentage
ContractWithCustomerLiabilityRevenueRecognizedPercentage
0.76
CY2024Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
35000
CY2023Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
20000
CY2024Q2 us-gaap Deferred Costs
DeferredCosts
44000
CY2023Q4 us-gaap Deferred Costs
DeferredCosts
2000
CY2024Q2 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
79000
CY2023Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
22000
CY2024Q2 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
6000
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
16000
CY2023Q2 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
17000
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
36000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
500000
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.85
CY2022Q2 aeye Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesValue
25000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
1500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
18960
CY2024Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
481040
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
975000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1031000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1858000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2149000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1550000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2037000
CY2024Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
349000
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
357000
CY2024Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
7000
CY2024Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.060
us-gaap Operating Lease Payments
OperatingLeasePayments
227000
us-gaap Operating Lease Payments
OperatingLeasePayments
271000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
127000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
219000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
225000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
571000
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
41000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
530000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
211000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
319000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
6000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
20000
aeye Finance Lease Interest Payment On Liabilities
FinanceLeaseInterestPaymentOnLiabilities
0
aeye Finance Lease Interest Payment On Liabilities
FinanceLeaseInterestPaymentOnLiabilities
1000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
6000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
21000
us-gaap Operating Lease Cost
OperatingLeaseCost
165000
us-gaap Operating Lease Cost
OperatingLeaseCost
266000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
204000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
117000
us-gaap Lease Cost
LeaseCost
375000
us-gaap Lease Cost
LeaseCost
404000
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y5M1D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y10M2D
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y9M10D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0600
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0600
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0600
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
35000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
12000
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 aeye Rule10b51 Arrangement Modified Flag
Rule10b51ArrangementModifiedFlag
false
CY2024Q2 aeye Non Rule10b51 Arrangement Modified Flag
NonRule10b51ArrangementModifiedFlag
false

Files In Submission

Name View Source Status
aeye-20240630_cal.xml Edgar Link unprocessable
aeye-20240630_pre.xml Edgar Link unprocessable
0001410578-24-001118-index-headers.html Edgar Link pending
0001410578-24-001118-index.html Edgar Link pending
0001410578-24-001118.txt Edgar Link pending
0001410578-24-001118-xbrl.zip Edgar Link pending
aeye-20240630.xsd Edgar Link pending
aeye-20240630x10q.htm Edgar Link pending
aeye-20240630x10q001.jpg Edgar Link pending
aeye-20240630xex31d1.htm Edgar Link pending
aeye-20240630xex31d2.htm Edgar Link pending
aeye-20240630xex32d1.htm Edgar Link pending
aeye-20240630xex3d3.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
aeye-20240630_lab.xml Edgar Link unprocessable
aeye-20240630x10q_htm.xml Edgar Link completed
aeye-20240630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable